Zoetis | ZTS - Current Assets


Zoetis reported $6.36B in Current Assets for its fiscal quarter ending in June of 2026.





Current Assets Change Date
AbbVie USD 33.67B 140M Jun/2026
Align Technology USD 2.66B 7.62M Jun/2026
Bayer EUR 33.64B 1.66B Jun/2026
Bristol-Myers Squibb USD 28.58B 1.37B Jun/2026
Charles River Laboratories USD 1.53B 40.3M Jun/2026
Coherus Biosciences USD 133.79M 72.25M Jun/2026
Dentsply International USD 1.93B 83M Jun/2026
Eli Lilly USD 64.67B 9.84B Jun/2026
Henry Schein USD 4.6B 104M Jun/2026
Idexx Laboratories USD 1.51B 55.41M Jun/2026
Illumina USD 2.83B 96M Jun/2026
IQVIA Holdings USD 6.45B 225M Sep/2026
J&J USD 56.35B 3.42B Sep/2026
Laboratory Of America USD 3.97B 151.3M Sep/2026
Merck USD 36.68B 1.66B Jun/2026
Neogen USD 582.5M 22.1M Jun/2026
Pacira USD 615.21M 100.25M Jun/2026
Perrigo USD 2.45B 260.7M Jun/2026
Pfizer USD 41.36B 1.46B Jun/2026
Phibro Animal Health USD 935.51M 41.44M Jun/2026
Quest Diagnostics USD 3.12B 273M Sep/2026
Sanofi EUR 31.52B 1.36B Jun/2026
Sanofi EUR 30.16B 789M Mar/2026
Zoetis USD 6.36B 118M Jun/2026